Skip to main content

CORRECTION article

Front. Cardiovasc. Med., 31 January 2022
Sec. Atherosclerosis and Vascular Medicine

Corrigendum: The Emerging Role of Rho Guanine Nucleotide Exchange Factors in Cardiovascular Disorders: Insights Into Atherosclerosis: A Mini Review

\nMengqi Li&#x;Mengqi Li1Qingzheng JiaoQingzheng Jiao2Wenqiang Xin,&#x;Wenqiang Xin3,4Shulin NiuShulin Niu5Mingming LiuMingming Liu6Yanxin SongYanxin Song7Zengguang Wang
Zengguang Wang4*Xinyu Yang
Xinyu Yang4*Degang Liang
Degang Liang1*
  • 1Department of Cardiovascular Surgery, Tianjin Medical University General Hospital, Tianjin, China
  • 2Second Department of Internal Medicine, Gucheng County Hospital, Hengshui Gucheng, Hebei, China
  • 3Department of Neurology, University of Göttingen Medical School, Göttingen, Germany
  • 4Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China
  • 5Department of Cardiology, Tianjin Medical University General Hospital, Tianjin, China
  • 6Department of Neurology and Immunology, Institute of Neurology, Tianjin Medical University General Hospital, Tianjin, China
  • 7Department of Nursing, Tianjin Medical University, Tianjin, China

A Corrigendum on
The Emerging Role of Rho Guanine Nucleotide Exchange Factors in Cardiovascular Disorders: Insights Into Atherosclerosis: A Mini Review

by Li, M., Jiao, Q., Xin, W., Niu, S., Liu, M., Song, Y., Wang, Z., Yang, X., and Liang, D. (2022). Front. Cardiovasc. Med. 8:782098. doi: 10.3389/fcvm.2021.782098

In the published article, there was an error in affiliation. Instead of Zengguang Wang3* and Xinyu Yang3*, it should be Zengguang Wang4* and Xinyu Yang4*.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: Rho GTPase, Rho GEF, atherosclerosis, mini-review, cardiovascular

Citation: Li M, Jiao Q, Xin W, Niu S, Liu M, Song Y, Wang Z, Yang X and Liang D (2022) Corrigendum: The Emerging Role of Rho Guanine Nucleotide Exchange Factors in Cardiovascular Disorders: Insights Into Atherosclerosis: A Mini Review. Front. Cardiovasc. Med. 9:850258. doi: 10.3389/fcvm.2022.850258

Received: 07 January 2022; Accepted: 10 January 2022;
Published: 31 January 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Li, Jiao, Xin, Niu, Liu, Song, Wang, Yang and Liang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Degang Liang, dliang@tmu.edu.cn; Xinyu Yang, yangxinyu@tmu.edu.cn; Zengguang Wang, wangzengguang@tmu.edu.cn

These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.